Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 64

1.

Distribution of Human papillomavirus load in clinical specimens.

Lowe B, O'Neil D, Loeffert D, Nazarenko I.

J Virol Methods. 2011 Apr;173(1):150-2. doi: 10.1016/j.jviromet.2011.01.018. Epub 2011 Feb 3.

PMID:
21295613
2.

The next-generation Hybrid Capture High-Risk HPV DNA assay on a fully automated platform.

Eder PS, Lou J, Huff J, Macioszek J.

J Clin Virol. 2009 Jul;45 Suppl 1:S85-92. doi: 10.1016/S1386-6532(09)70013-7.

PMID:
19651374
3.

Comparison of HPV detection technologies: Hybrid capture 2, PreTect HPV-Proofer and analysis of HPV DNA viral load in HPV16, HPV18 and HPV33 E6/E7 mRNA positive specimens.

Keegan H, Mc Inerney J, Pilkington L, Grønn P, Silva I, Karlsen F, Bolger N, Logan C, Furuberg L, O'Leary J, Martin C.

J Virol Methods. 2009 Jan;155(1):61-6. doi: 10.1016/j.jviromet.2008.09.027. Epub 2008 Nov 13.

PMID:
18955086
4.

Efficiency of the APTIMA HPV Assay for detection of HPV RNA and DNA targets.

Getman D, Aiyer A, Dockter J, Giachetti C, Zhang F, Ginocchio CC.

J Clin Virol. 2009 Jul;45 Suppl 1:S49-54. doi: 10.1016/S1386-6532(09)70008-3.

PMID:
19651369
5.

An HPV 16, 18, and 45 genotyping test based on Hybrid Capture technology.

Thai H, Rangwala S, Gay T, Keating K, McLeod S, Nazarenko I, O'Neil D, Pfister D, Loeffert D.

J Clin Virol. 2009 Jul;45 Suppl 1:S93-7. doi: 10.1016/S1386-6532(09)70014-9.

PMID:
19651375
6.

Clinical performance of the APTIMA HPV Assay for the detection of high-risk HPV and high-grade cervical lesions.

Dockter J, Schroder A, Hill C, Guzenski L, Monsonego J, Giachetti C.

J Clin Virol. 2009 Jul;45 Suppl 1:S55-61. doi: 10.1016/S1386-6532(09)70009-5.

PMID:
19651370
7.

Restricted cross-reactivity of hybrid capture 2 with nononcogenic human papillomavirus types.

Castle PE, Schiffman M, Burk RD, Wacholder S, Hildesheim A, Herrero R, Bratti MC, Sherman ME, Lorincz A.

Cancer Epidemiol Biomarkers Prev. 2002 Nov;11(11):1394-9.

8.

Human papillomavirus detection by the hybrid capture II assay: a reliable test to select women with normal cervical smears at risk for developing cervical lesions.

Clavel C, Masure M, Levert M, Putaud I, Mangeonjean C, Lorenzato M, Nazeyrollas P, Gabriel R, Quereux C, Birembaut P.

Diagn Mol Pathol. 2000 Sep;9(3):145-50.

PMID:
10976721
9.

A comparison between real-time polymerase chain reaction and hybrid capture 2 for human papillomavirus DNA quantitation.

Gravitt PE, Burk RD, Lorincz A, Herrero R, Hildesheim A, Sherman ME, Bratti MC, Rodriguez AC, Helzlsouer KJ, Schiffman M.

Cancer Epidemiol Biomarkers Prev. 2003 Jun;12(6):477-84.

10.

Human papillomavirus (HPV) DNA copy number is dependent on grade of cervical disease and HPV type.

Swan DC, Tucker RA, Tortolero-Luna G, Mitchell MF, Wideroff L, Unger ER, Nisenbaum RA, Reeves WC, Icenogle JP.

J Clin Microbiol. 1999 Apr;37(4):1030-4.

11.

Comparison between the Hybrid Capture 2 and the hpVIR real-time PCR for detection of human papillomavirus in women with ASCUS or low grade dysplasia.

Gustavsson I, Juko-Pecirep I, Backlund I, Wilander E, Gyllensten U.

J Clin Virol. 2009 Jun;45(2):85-9. doi: 10.1016/j.jcv.2009.04.012. Epub 2009 May 17.

PMID:
19451022
12.

[Evaluation of gene chip technology for high risk type human papillomavirus in cervical cancer screening].

Li RZ, Shi JF, Zhou QZ, Wu RF, Li N, Wu LN, Zhou YQ, Wang Q, Liu ZH, Liu B, Qiao YL.

Zhonghua Yi Xue Za Zhi. 2006 Feb 7;86(5):307-11. Chinese.

PMID:
16677522
13.

Comparison of the Digene HC2 assay and the Roche AMPLICOR human papillomavirus (HPV) test for detection of high-risk HPV genotypes in cervical samples.

Sandri MT, Lentati P, Benini E, Dell'Orto P, Zorzino L, Carozzi FM, Maisonneuve P, Passerini R, Salvatici M, Casadio C, Boveri S, Sideri M.

J Clin Microbiol. 2006 Jun;44(6):2141-6.

15.
16.

Clinical performance of Abbott RealTime High Risk HPV test for detection of high-grade cervical intraepithelial neoplasia in women with abnormal cytology.

Huang S, Erickson B, Tang N, Mak WB, Salituro J, Robinson J, Abravaya K.

J Clin Virol. 2009 Jul;45 Suppl 1:S19-23. doi: 10.1016/S1386-6532(09)70004-6.

PMID:
19651364
17.

Analytical evaluation of the PapilloCheck test, a new commercial DNA chip for detection and genotyping of human papillomavirus.

Dalstein V, Merlin S, Bali C, Saunier M, Dachez R, Ronsin C.

J Virol Methods. 2009 Mar;156(1-2):77-83. doi: 10.1016/j.jviromet.2008.11.002. Epub 2008 Dec 17.

PMID:
19041893
18.

Comparison of the hybrid capture II assay with the human papillomavirus DNA chip test for the detection of high-grade cervical lesions.

Kang WD, Kim CH, Cho MK, Kim JW, Kim YH, Choi HS, Kim SM.

Int J Gynecol Cancer. 2009 Jul;19(5):924-8. doi: 10.1111/IGC.0b013e3181a832a2.

PMID:
19574786
19.

Human papillomavirus (HPV) in atypical squamous cervical cytology: the Invader HPV test as a new screening assay.

Wong AK, Chan RC, Nichols WS, Bose S.

J Clin Microbiol. 2008 Mar;46(3):869-75. doi: 10.1128/JCM.01424-07. Epub 2008 Jan 3.

20.

Human papillomavirus testing methods.

Hubbard RA.

Arch Pathol Lab Med. 2003 Aug;127(8):940-5. Review.

PMID:
12873165

Supplemental Content

Support Center